RxDoctor Payments Data

Thang Luong, DO

Family Medicine · Davenport, IANPI 1053791681

Payments from drug & device makers

$1,008in general payments, 2019–2025

Across 60 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$244
  • Amgen$231
  • Mylan Specialty L.p.$219
  • Organogenesis Inc.$75
  • Pfizer$70
  • Lilly USA, LLC$49
  • plus $119 from 4 others

What the payments were for

  • Speaking & faculty fees$364%
  • Food & beverage$95895%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,008 in reported general payments places this provider in the 80th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$13,803
Medicare patients
49
Services billed
217

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide116$133,806
JardianceEmpagliflozin45$38,285
EliquisApixaban66$38,118
XareltoRivaroxaban46$26,064
TrulicityDulaglutide25$23,879
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$18,606
JanuviaSitagliptin Phosphate19$10,955
Advair HfaFluticasone Propion/Salmeterol18$9,928
RexultiBrexpiprazole12$8,703
ArexvyRsvpref3 Antigen/As01e/Pf28$8,164
MyrbetriqMirabegron12$5,332
Novolog FlexpenInsulin Aspart25$3,697
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate20$3,520
ShingrixVaricella-Zoster Ge/As01b/Pf16$3,460
Pregabalin113$3,413

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$244$133,806116 claims
PfizerEliquis$70$38,11866 claims
Lilly USA, LLCTrulicity$49$23,87925 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Davenport

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →